Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Detlef Bartkowiak

Showing results (11-20 of 33) with videos related to

Pageof 4
Sort By:
Prostate Cancer and Prostatic Diseases|November 30, 2018
Effect of early salvage radiotherapy at PSA < 0.5 ng/ml and impact of post-SRT PSA nadir in post-prostatectomy recurrent prostate cancerDirk Bottke, Detlef Bartkowiak, Alessandra Siegmann, et al.
Strahlentherapie Und Onkologie : Organ Der Deutschen Rontgengesellschaft ... [Et Al]|March 27, 2010
Second malignancies in high‑dose areas of previous tumor radiotherapyBirgitta Welte, Peter Suhr, Dirk Bottke, et al.
World Journal of Urology|March 31, 2012
Salvage radiotherapy in patients with persistently detectable PSA or PSA rising from an undetectable range after radical prostatectomy gives comparable resultsGunnar Lohm, Dirk Bottke, Basil Jamil, et al.
Strahlentherapie Und Onkologie : Organ Der Deutschen Rontgengesellschaft ... [Et Al]|July 26, 2011
Dose escalation for patients with decreasing PSA during radiotherapy for elevated PSA after radical prostatectomy improves biochemical progression-free survival: results of a retrospective studyAlessandra Siegmann, Dirk Bottke, Julia Faehndrich, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|February 15, 2016
Radiation dose distribution in functional heart regions from tangential breast cancer radiotherapyDaniel Wollschläger, Heiko Karle, Marcus Stockinger, et al.
Breast Cancer Research and Treatment|November 3, 2016
3D conformal radiotherapy is not associated with the long-term cardiac mortality in breast cancer patients: a retrospective cohort study in Germany (PASSOS-Heart Study)Hiltrud Merzenich, Detlef Bartkowiak, Heinz Schmidberger, et al.
Health Physics|December 2, 2016
Predicting Heart Dose in Breast Cancer Patients Who Received 3D Conformal Radiation TherapyDaniel Wollschläger, Heiko Karle, Marcus Stockinger, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|November 29, 2011
Salvage radiotherapy after prostatectomy - what is the best time to treat?Alessandra Siegmann, Dirk Bottke, Julia Faehndrich, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|October 14, 2011
Second cancer after radiotherapy, 1981-2007Detlef Bartkowiak, Nicole Humble, Peter Suhr, et al.
Strahlentherapie Und Onkologie : Organ Der Deutschen Rontgengesellschaft ... [Et Al]|May 5, 2017
Defining biochemical recurrence after radical prostatectomy and timing of early salvage radiotherapy : Informing the debateLars Budäus, Jonas Schiffmann, Markus Graefen, et al.
Pageof 4

Showing results (11-20 of 33) with videos related to

Sort By:
Pageof 4
Prostate Cancer and Prostatic Diseases|November 30, 2018
Effect of early salvage radiotherapy at PSA < 0.5 ng/ml and impact of post-SRT PSA nadir in post-prostatectomy recurrent prostate cancerDirk Bottke, Detlef Bartkowiak, Alessandra Siegmann, et al.
Strahlentherapie Und Onkologie : Organ Der Deutschen Rontgengesellschaft ... [Et Al]|March 27, 2010
Second malignancies in high‑dose areas of previous tumor radiotherapyBirgitta Welte, Peter Suhr, Dirk Bottke, et al.
World Journal of Urology|March 31, 2012
Salvage radiotherapy in patients with persistently detectable PSA or PSA rising from an undetectable range after radical prostatectomy gives comparable resultsGunnar Lohm, Dirk Bottke, Basil Jamil, et al.
Strahlentherapie Und Onkologie : Organ Der Deutschen Rontgengesellschaft ... [Et Al]|July 26, 2011
Dose escalation for patients with decreasing PSA during radiotherapy for elevated PSA after radical prostatectomy improves biochemical progression-free survival: results of a retrospective studyAlessandra Siegmann, Dirk Bottke, Julia Faehndrich, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|February 15, 2016
Radiation dose distribution in functional heart regions from tangential breast cancer radiotherapyDaniel Wollschläger, Heiko Karle, Marcus Stockinger, et al.
Breast Cancer Research and Treatment|November 3, 2016
3D conformal radiotherapy is not associated with the long-term cardiac mortality in breast cancer patients: a retrospective cohort study in Germany (PASSOS-Heart Study)Hiltrud Merzenich, Detlef Bartkowiak, Heinz Schmidberger, et al.
Health Physics|December 2, 2016
Predicting Heart Dose in Breast Cancer Patients Who Received 3D Conformal Radiation TherapyDaniel Wollschläger, Heiko Karle, Marcus Stockinger, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|November 29, 2011
Salvage radiotherapy after prostatectomy - what is the best time to treat?Alessandra Siegmann, Dirk Bottke, Julia Faehndrich, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|October 14, 2011
Second cancer after radiotherapy, 1981-2007Detlef Bartkowiak, Nicole Humble, Peter Suhr, et al.
Strahlentherapie Und Onkologie : Organ Der Deutschen Rontgengesellschaft ... [Et Al]|May 5, 2017
Defining biochemical recurrence after radical prostatectomy and timing of early salvage radiotherapy : Informing the debateLars Budäus, Jonas Schiffmann, Markus Graefen, et al.
Pageof 4